Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Pacira BioSciences, Inc.

PCRX · Nasdaq · CIK 0001396814 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

21 Form 4 transaction lines observed in the same window
7 sales · 14 option, withholding, award, gift or other lines

Last qualifying purchase2024-08-16 · BIGAL MARCELO · $20.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Cross ShawnChief Financial Officer
○▼○▼○▼
RIKER LAURENSenior Vice President, Finance
○▼○▼
WILLIAMS KRISTENChief Administrative Officer
○▼
SLONIN JONATHANChief Medical Officer
○▼
Young AlethiaDirector
○
YANG MICHAEL J.Director
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-08-16 · BIGAL MARCELO.

Recent Form 4 activity

0Purchases
17Sales
33Other Form 4 lines
36SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING7 sale line(s) · context only
OTHER14 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
8,076,461
Previous report
7,561,153
Avg daily volume
536,467
Days to cover
15.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2024-08-16Brege LauraPurchase (P)Common Stock1,000USD 12.81USD 12,810SEC filing ↗
2024-08-16BIGAL MARCELOPurchase (P)Common Stock1,512USD 13.25USD 20,034SEC filing ↗
2024-08-14YANG MICHAEL J.Purchase (P)Common Stock2,000USD 12.90USD 25,800SEC filing ↗
2024-08-12Lee Frank D.Purchase (P)Common Stock8,264USD 12.10USD 99,994SEC filing ↗
2024-08-12BIGAL MARCELOPurchase (P)Common Stock3,400USD 12.01USD 40,834SEC filing ↗
2024-08-12Froimson MarkPurchase (P)Common Stock1,400USD 11.58USD 16,212SEC filing ↗
2024-08-12BIGAL MARCELOPurchase (P)Common Stock3,400USD 12.01USD 40,834SEC filing ↗
2020-03-11WINSTON ROYPurchase (P)Common Stock2,500USD 36.50USD 91,250SEC filing ↗

Form 4 evidence

50 transaction lines in the latest 365-day window; 497 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-08RIKER LAURENSale (S)Common Stock6,000USD 36.32USD 217,920SEC filing ↗
2026-10-08RIKER LAURENOption exercise / conversion (M)Common Stock6,000USD 32.35USD 194,100SEC filing ↗
2026-08-17SLONIN JONATHANSale (S)Common Stock3,040USD 23.23USD 70,619SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-08RIKER LAURENSale (S)Common Stock6,000USD 36.32USD 217,920SEC filing ↗
2026-10-08RIKER LAURENOption exercise / conversion (M)Common Stock6,000USD 32.35USD 194,100SEC filing ↗
2026-08-17SLONIN JONATHANSale (S)Common Stock3,040USD 23.23USD 70,619SEC filing ↗
2026-06-11RIKER LAURENSale (S)Common Stock6,115USD 23.50USD 143,702SEC filing ↗
2026-06-10Young AlethiaAward / grant (A)Common Stock6,405USD 0.00USD 0SEC filing ↗
2026-06-10YANG MICHAEL J.Award / grant (A)Common Stock6,405USD 0.00USD 0SEC filing ↗
2026-06-10Hirawat SamitAward / grant (A)Common Stock6,405USD 0.00USD 0SEC filing ↗
2026-06-10Froimson MarkAward / grant (A)Common Stock6,405USD 0.00USD 0SEC filing ↗
2026-06-10CHRISTIE CHRISTOPHERAward / grant (A)Common Stock6,405USD 0.00USD 0SEC filing ↗
2026-06-10Brege LauraAward / grant (A)Common Stock6,405USD 0.00USD 0SEC filing ↗
2026-06-10BIGAL MARCELOAward / grant (A)Common Stock6,405USD 0.00USD 0SEC filing ↗
2026-06-04WILLIAMS KRISTENSale (S)Common Stock10,259USD 22.27USD 228,468SEC filing ↗
2026-06-03WILLIAMS KRISTENTax withholding (F)Common Stock8,528USD 22.32USD 190,345SEC filing ↗
2026-06-03SLONIN JONATHANTax withholding (F)Common Stock4,728USD 22.32USD 105,529SEC filing ↗
2026-06-03RIKER LAURENTax withholding (F)Common Stock3,187USD 22.32USD 71,134SEC filing ↗
2026-04-23Cross ShawnSale (S)Common Stock12,941USD 25.16USD 325,596SEC filing ↗
2026-04-23Cross ShawnOption exercise / conversion (M)Common Stock12,941USD 16.45USD 212,879SEC filing ↗
2026-04-22Cross ShawnSale (S)Common Stock1,500USD 25.01USD 37,515SEC filing ↗
2026-04-22Cross ShawnOption exercise / conversion (M)Common Stock1,500USD 16.45USD 24,675SEC filing ↗
2026-04-21Cross ShawnSale (S)Common Stock2,845USD 25.01USD 71,153SEC filing ↗
2026-04-21Cross ShawnOption exercise / conversion (M)Common Stock2,845USD 16.45USD 46,800SEC filing ↗
2026-04-20Cross ShawnSale (S)Common Stock7,714USD 25.14USD 193,930SEC filing ↗
2026-04-20Cross ShawnOption exercise / conversion (M)Common Stock7,714USD 16.45USD 126,895SEC filing ↗
2026-03-17SLONIN JONATHANSale (S)Common Stock3,261USD 22.82USD 74,416SEC filing ↗
2026-03-17Froimson MarkSale (S)Common Stock500USD 21.81USD 10,905SEC filing ↗
2026-02-11WILLIAMS KRISTENAward / grant (A)Common Stock54,546USD 0.00USD 0SEC filing ↗
2026-02-11Teehan BrendanAward / grant (A)Common Stock51,714USD 0.00USD 0SEC filing ↗
2026-02-11SLONIN JONATHANAward / grant (A)Common Stock54,546USD 0.00USD 0SEC filing ↗
2026-02-11RIKER LAURENAward / grant (A)Common Stock19,273USD 0.00USD 0SEC filing ↗
2026-02-11Lee Frank D.Award / grant (A)Common Stock261,818USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerPCRX
CIK0001396814
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history497 transaction lines from 2020-01-15 to 2026-10-08
8 P purchase lines · 231 S sale lines · 258 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.